Fournès, B <br/><br/>
The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.  [electronic resource] 

 -  Oncogene  Jan 2001 
 - 219-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1204058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--analogs & derivatives<br/>Amino Acid Sequence<br/>Animals<br/>Antigens, CD--genetics<br/>Antigens, Differentiation--genetics<br/>Calcium-Calmodulin-Dependent Protein Kinases--antagonists & inhibitors<br/>Carcinoembryonic Antigen<br/>Carcinogenicity Tests<br/>Carcinoma--drug therapy<br/>Cell Adhesion Molecules<br/>Colonic Neoplasms--drug therapy<br/>Cyclic AMP--analogs & derivatives<br/>Enzyme Inhibitors--pharmacology<br/>Epithelial Cells--metabolism<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Molecular Sequence Data<br/>Naphthalenes--pharmacology<br/>Point Mutation<br/>Protein Kinase C--antagonists & inhibitors<br/>Serine--metabolism<br/>Staurosporine--pharmacology<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Thionucleotides--pharmacology<br/>Tumor Cells, Cultured